Singapore's industrial landscape faced a dramatic twist in December 2025, with a staggering 13.3% month-on-month plunge in production. But here's where it gets intriguing: this decline was almost entirely driven by a whopping 85.8% drop in pharmaceuticals output. Is this a cause for panic, or a temporary blip in an otherwise resilient economy? Let's dive deeper.
Despite the headline-grabbing decline, Singapore's industrial sector demonstrated remarkable year-on-year growth of 8.3%. This resilience was fueled by standout performances in key sectors. The electronics industry, for instance, soared by 30.8% year-on-year, up from 18.1% in November, riding the wave of surging demand for AI-related products. And this is the part most people miss: the transport engineering sector also flexed its muscles, growing by 19.9% year-on-year, with aerospace leading the charge at an impressive 35.9% increase.
But what does this mean for investors and traders? The pharmaceuticals sector's volatility is nothing new. Historically, this sector has seen extreme swings tied to the production schedules of a few large plants. In 2023 and 2024, similar dips in biomedical output were swiftly followed by sharp corrections in subsequent quarters. So, should you bet against this sector now? Not so fast. Aggressive short positions based on a single data point could be risky. A more prudent approach might be to await January’s figures or use options to manage risk.
Now, let’s talk about the real growth engines: electronics and transport engineering. The electronics sector’s robust growth aligns with the World Semiconductor Trade Statistics (WSTS) organization’s recent upgrade of its 2026 global market forecast to 15% growth, citing the AI infrastructure boom. This trend suggests that long positions in semiconductor-related stocks or ETFs could be a smart move. Similarly, the transport engineering sector’s strength, particularly in aerospace, is backed by global airline earnings reports highlighting increased demand for aircraft maintenance and services in the Asia-Pacific region.
But here's the controversial part: while these sectors shine, the Singapore Dollar’s outlook remains complex. Strong export performance in electronics and transport is undoubtedly positive, but December 2025’s CPI data revealed that core inflation remains above the central bank’s target. This could prompt the Monetary Authority of Singapore to maintain its tightening stance, potentially supporting the currency despite weak headline production numbers. So, is the Singapore Dollar a buy, hold, or sell in this scenario?
As we navigate these contrasting trends, one thing is clear: Singapore’s industrial landscape is a tale of two stories—volatility in pharmaceuticals versus resilience in electronics and transport engineering. The question is, how will you position yourself in this dynamic market? What’s your take on these sectors? Do you see the pharmaceuticals decline as a buying opportunity, or a red flag? Share your thoughts in the comments below!
Ready to explore these opportunities? Create your live VT Markets account here and start trading now.
